FRLN(Delisted)
FreelineยทNASDAQ
--
--(--)
FRLN Profile
Freeline Therapeutics Holdings Plc
A clinical-stage biotechnology company that developing transformative adeno-associated virus (AAV) vector-mediated systemic gene therapies
--
04/03/2020
08/07/2020
NASDAQ Stock Exchange
152
12-31
Depository Receipts (Ordinary Shares)
Sycamore House, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2BP, United Kingdom
--
Freeline Therapeutics Holdings Plc was incorporated in England and Wales on April 3, 2020. The company is a clinical-stage, fully integrated next-generation system-based AAV gene therapy company that aims to transform the lives of patients with inherited systemic debilitating diseases. The company aims to provide one-time gene therapy, which can be achieved through a proprietary gene therapy platform, providing functional treatment through permanent and continuous physiological protein levels.
